Exhibit 10.3


 


 


Secured Promissory
Note


 





	Effective Date: May 20, 2022	U.S. $6,015,000.00






 


FOR VALUE RECEIVED, Nemaura
Medical Inc., a Nevada corporation (“Company”), Dermal Diagnostics Limited,
an England and Wales corporation (“Dermal Diagnostics”), and Trial Clinic Limited,
an England and Wales corporation (“Trial Clinic,” and together with Dermal Diagnostics, “Borrower”),
jointly and severally promise to pay to Streeterville Capital, LLC, a Utah limited liability
company, or its successors or assigns (“Lender”), $6,015,000.00 and any fees, charges, and late fees accrued hereunder
on the date that is twenty-four (24) months after the Purchase Price Date (the “Maturity Date”) in accordance with
the terms set forth herein. This Secured Promissory Note (this “Note”) is issued and made effective as of May 20, 2022
(the “Effective Date”). This Note is issued pursuant to that certain Note Purchase Agreement dated May 20, 2022, as
the same may be amended from time to time, by and between Borrower and Lender (the “Purchase Agreement”). Certain capitalized
terms used herein are defined in Attachment 1 attached hereto and incorporated herein by this reference.


This Note carries an OID
of $1,000,000.00. In addition, Borrower agrees to pay $15,000.00 to Lender to cover Lender’s legal fees, accounting costs, due diligence,
monitoring and other transaction costs incurred in connection with the purchase and sale of this Note (the “Transaction Expense
Amount”), all of which amount is fully earned and included in the initial principal balance of this Note. The purchase price
for this Note shall be $5,000,000.00 (the “Purchase Price”), computed as follows: $6,015,000.00 original principal
balance, less the OID, less the Transaction Expense Amount. The Purchase Price shall be payable by Lender by wire transfer of immediately
available funds.


1.
Payment; Prepayment; Monitoring Fee.


1.1.
Payment. All payments owing hereunder shall be in lawful money of the United States of America
and delivered to Lender at the address or bank account furnished to Borrower for that purpose. All payments shall be applied first to
(a) costs of collection, if any, then to (b) fees and charges, if any, then to (c) accrued and unpaid monitoring fees, and thereafter,
to (d) principal. 


1.2.
Prepayment. Borrower shall have the right to prepay all or any portion of the Outstanding
Balance. If Borrower exercises its right to prepay this Note, Borrower shall make payment to Lender of an amount in cash equal to 110%
multiplied by the portion of the Outstanding Balance Borrower elects to prepay.


1.3.
Monitoring Fee. Beginning on June 1, 2022 and continuing on the first day of each month thereafter
until this Note has been paid in full, a monitoring fee equal to 0.833% of the then-current Outstanding Balance will automatically be
added to the Outstanding Balance. 


2.
Security. This Note is secured by the Security Agreement (as defined in the Purchase Agreement),
executed by Borrower in favor of Lender encumbering the collateral set forth therein, as more specifically set forth in the Security Agreement,
all the terms and conditions of which are hereby incorporated into and made a part of this Note. 


3.
Redemption. Beginning on the date that is six (6) months after the Purchase Price Date, Lender
shall have the right, exercisable at any time in its sole and absolute discretion, to redeem any amount of this Note up to the Maximum
Monthly Redemption Amount (such amount, the “Redemption Amount”) per calendar month by providing written notice to
Borrower (each, a “Redemption Notice”). For the avoidance of doubt, Lender may submit to Borrower one (1) or more
Redemption Notices in any given calendar month so long as the aggregate amount being redeemed in such month does not exceed the Maximum
Monthly Redemption Amount. Upon receipt of any Redemption Notice, Borrower shall pay the applicable Redemption Amount in cash to Lender
within five (5) Trading Days of Borrower’s receipt of such Redemption Notice. 






    	1 



    	 



    

4.
Defaults and Remedies.


4.1.
Defaults. The following are events of default under this Note (each, an “Event of
Default”): (a) Borrower fails to pay any principal, monitoring or other fees, charges, or any other amount when due and payable
hereunder; (b) a receiver, trustee or other similar official shall be appointed over Borrower or a material part of its assets and such
appointment shall remain uncontested for twenty (20) days or shall not be dismissed or discharged within sixty (60) days; (c) Borrower
becomes insolvent or generally fails to pay, or admits in writing its inability to pay, its debts as they become due, subject to applicable
grace periods, if any; (d) Borrower makes a general assignment for the benefit of creditors; (e) Borrower files a petition for relief
under any bankruptcy, insolvency or similar law (domestic or foreign); (f) an involuntary bankruptcy proceeding is commenced or filed
against Borrower; (g) Borrower or any pledgor, trustor, or guarantor of this Note defaults or otherwise fails to observe or perform any
covenant, obligation, condition or agreement of Borrower or such pledgor, trustor, or guarantor contained herein or in any other Transaction
Document (as defined in the Purchase Agreement); (h) the occurrence of a Fundamental Transaction without Lender’s prior written
consent; (i) any representation, warranty or other statement made or furnished by or on behalf of Borrower or any pledgor, trustor, or
guarantor of this Note to Lender herein, in any Transaction Document, or otherwise in connection with the issuance of this Note is false,
incorrect, incomplete or misleading in any material respect when made or furnished; and (j) any United States money judgment, writ or
similar process is entered or filed against Borrower or any subsidiary of Borrower or any of its property or other assets for more than
$1,000,000.00, and shall remain unvacated, unbonded or unstayed for a period of twenty (20) calendar days unless otherwise consented to
by Lender. The occurrence of any event described above in Section 4.1(g) – (j) shall not be considered an Event of Default hereunder
if such event is cured within fifteen (15) days of the occurrence thereof. 


4.2.
Remedies. At any time and from time to time after Lender becomes aware of the occurrence of
any Event of Default, Lender may accelerate this Note by written notice to Borrower, with the Outstanding Balance becoming immediately
due and payable in cash at the Mandatory Default Amount. Notwithstanding the foregoing, at any time following the occurrence of any Event
of Default, Lender may, at its option, elect to increase the Outstanding Balance by applying the Default Effect (subject to the limitation
set forth below) via written notice to Borrower without accelerating the Outstanding Balance, in which event the Outstanding Balance shall
be increased as of the date of the occurrence of the applicable Event of Default pursuant to the Default Effect, but the Outstanding Balance
shall not be immediately due and payable unless so declared by Lender (for the avoidance of doubt, if Lender elects to apply the Default
Effect pursuant to this sentence, it shall reserve the right to declare the Outstanding Balance immediately due and payable at any time
and no such election by Lender shall be deemed to be a waiver of its right to declare the Outstanding Balance immediately due and payable
as set forth herein unless otherwise agreed to by Lender in writing). Notwithstanding the foregoing, upon the occurrence of any Event
of Default described in clauses (b), (c), (d), (e) or (f) of Section 4.1, the Outstanding Balance as of the date of acceleration shall
become immediately and automatically due and payable in cash at the Mandatory Default Amount, without any written notice required by Lender.
At any time following the occurrence of any Event of Default, upon written notice given by Lender to Borrower, monitoring fees shall accrue
on the Outstanding Balance beginning on the date the applicable Event of Default occurred at a rate equal to the lesser of twenty-two
percent (22%) per annum or the maximum rate permitted under applicable law (“Default Monitoring Fees”). In connection
with acceleration described herein, Lender need not provide, and Borrower hereby waives, any presentment, demand, protest or other notice
of any kind, and Lender may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder
and all other remedies available to it under applicable law. Such acceleration may be rescinded and annulled by Lender at any time prior
to payment hereunder and Lender shall have all rights as a holder of the Note until such time, if any, as Lender receives full payment
pursuant to this Section 4.2. No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent
thereon. Nothing herein shall limit Lender’s right to pursue any other remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief.


5.
Unconditional Obligation; No Offset. Borrower acknowledges that this Note is an unconditional,
valid, binding and enforceable obligation of Borrower not subject to offset, deduction or counterclaim of any kind. Borrower hereby waives
any rights of offset it now has or may have hereafter against Lender, its successors and assigns, and agrees to make the payments called
for herein in accordance with the terms of this Note.


 






    	2 



    	 



    

6.
Waiver. No waiver of any provision of this Note shall be effective unless it is in the form
of a writing signed by the party granting the waiver. No waiver of any provision or consent to any prohibited action shall constitute
a waiver of any other provision or consent to any other prohibited action, whether or not similar. No waiver or consent shall constitute
a continuing waiver or consent or commit a party to provide a waiver or consent in the future except to the extent specifically set forth
in writing.


7.
Opinion of Counsel. In the event that an opinion of counsel is needed for any matter related
to this Note, Lender has the right to have any such opinion provided by its counsel. 


8.
Governing Law; Venue. This Note shall be construed and enforced in accordance with, and all
questions concerning the construction, validity, interpretation and performance of this Note shall be governed by, the internal laws of
the State of Utah, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Utah or any
other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Utah. The provisions set
forth in the Purchase Agreement to determine the proper venue for any disputes are incorporated herein by this reference.


9.
Arbitration of Disputes. By its issuance or acceptance of this Note, each party agrees to
be bound by the Arbitration Provisions (as defined in the Purchase Agreement) set forth as an exhibit to the Purchase Agreement.


10.
Cancellation. After repayment of the entire Outstanding Balance, this Note shall be deemed
paid in full, shall automatically be deemed canceled, and shall not be reissued.


11.
Amendments. The prior written consent of both parties hereto shall be required for any change
or amendment to this Note.


12.
Assignments. Borrower may not assign this Note without the prior written consent of Lender.
This Note may be offered, sold, assigned or transferred by Lender without the consent of Borrower, so long as such transfer is in accordance
with applicable federal and state securities laws.


13.
Notices. Whenever notice is required to be given under this Note, unless otherwise provided
herein, such notice shall be given in accordance with the subsection of the Purchase Agreement titled “Notices.”


14.
Liquidated Damages. Lender and Borrower agree that in the event Borrower fails to comply with
any of the terms or provisions of this Note, Lender’s damages would be uncertain and difficult (if not impossible) to accurately
estimate because of the parties’ inability to predict future rates, future share prices, future trading volumes and other relevant
factors. Accordingly, Lender and Borrower agree that any fees, balance adjustments, Default Monitoring Fees or other charges assessed
under this Note are not penalties but instead are intended by the parties to be, and shall be deemed, liquidated damages.


15.
Severability. If any part of this Note is construed to be in violation of any law, such part
shall be modified to achieve the objective of Borrower and Lender to the fullest extent permitted by law and the balance of this Note
shall remain in full force and effect.


16.
Joint and Several Obligations. To the extent applicable, any references in this Note to Borrower
refer to each person or entity constituting Borrower jointly and severally, and all promises, agreements, covenants, waivers, consents,
representations, warranties, and other provisions in this Note are made by and are binding upon each such undersigned person or entity,
jointly and severally.


[Remainder of page intentionally left blank; signature
page follows]


 






    	3 



    	 



    

 




IN WITNESS WHEREOF, Borrower
has caused this Note to be duly executed as of the Effective Date.


BORROWER:


Nemaura
Medical Inc.


 


 


By: /s/ Dewan F.H. Chowdhury


Name: Dewan F.H. Chowdhury


Title: CEO


 


 


Dermal
Diagnostics Limited


 


 


By: /s/ Dewan F.H. Chowdhury


Name: Dewan F.H. Chowdhury


Title: Director


 


 


Trial
Clinic Limited


 


 


By: /s/ Dewan F.H. Chowdhury


Name: Dewan F.H. Chowdhury


Title: Director


 


 


ACKNOWLEDGED, ACCEPTED AND AGREED:


LENDER:


Streeterville
Capital, LLC


 


 


By: /s/ John M. Fife


John M. Fife, President


 


 


 


 


 




    	 



    	 



    


ATTACHMENT 1


DEFINITIONS


 


For purposes of this
Note, the following terms shall have the following meanings:


A1.
“Default Effect” means multiplying the Outstanding Balance as of the date the Event of Default occurred by ten
percent (10%).


A2.
“DTC” means the Depository Trust Company or any successor thereto.


A3.
“DTC/FAST Program” means the DTC’s Fast Automated Securities Transfer program.


A4.
“DWAC” means the DTC’s Deposit/Withdrawal at Custodian system.


A5.
“DWAC Eligible” means that (a) Company’s Common Stock is eligible at DTC for full services pursuant to
DTC’s operational arrangements, including without limitation transfer through DTC’s DWAC system; (b) Company has been approved
(without revocation) by DTC’s underwriting department; (c) Company’s transfer agent is approved as an agent in the DTC/FAST
Program; and (d) Company’s transfer agent does not have a policy prohibiting or limiting delivery of Common Stock via DWAC.


A6.
“Fundamental Transaction” means that (a) (i) Borrower or any of its subsidiaries shall, directly or indirectly,
in one or more related transactions, consolidate or merge with or into (whether or not Borrower or any of its subsidiaries is the surviving
corporation) any other person or entity, or (ii) Borrower or any of its subsidiaries shall, directly or indirectly, in one or more
related transactions, sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its respective
properties or assets to any other person or entity, or (iii) Borrower or any of its subsidiaries shall, directly or indirectly, in
one or more related transactions, allow any other person or entity to make a purchase, tender or exchange offer that is accepted by the
holders of more than 50% of the outstanding shares of voting stock of Borrower (not including any shares of voting stock of Borrower held
by the person or persons making or party to, or associated or affiliated with the persons or entities making or party to, such purchase,
tender or exchange offer), or (iv) Borrower or any of its subsidiaries shall, directly or indirectly, in one or more related transactions,
consummate a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with any other person or entity whereby such other person or entity acquires more than 50% of the outstanding
shares of voting stock of Borrower (not including any shares of voting stock of Borrower held by the other persons or entities making
or party to, or associated or affiliated with the other persons or entities making or party to, such stock or share purchase agreement
or other business combination), or (v) Borrower or any of its subsidiaries shall, directly or indirectly, in one or more related
transactions, reorganize, recapitalize or reclassify the Common Stock, other than an increase in the number of authorized shares of Borrower’s
Common Stock, or reverse splits of its outstanding and authorized shares of Common Stock to meet Nasdaq listing requirements or (b) any
“person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act and the
rules and regulations promulgated thereunder) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under
the 1934 Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented by issued and outstanding voting stock
of Borrower.


A7.
“Mandatory Default Amount” means the Outstanding Balance following the application of the Default Effect.


A8.
“Maximum Monthly Redemption Amount” means $100,000.00 until April 30, 2023 and $500,000.00 thereafter.


A9.
“OID” means an original issue discount.


A10.
“Other Agreements” means, collectively, (a) all existing and future agreements and instruments between, among
or by Borrower (or an affiliate), on the one hand, and Lender (or an affiliate), on the other hand, and (b) any financing agreement or
a material agreement that affects Borrower’s ongoing business operations.


A11.
“Outstanding Balance” means as of any date of determination, the Purchase Price, as reduced or increased, as
the case may be, pursuant to the terms hereof for payment, offset, or otherwise, plus the OID, the Transaction Expense Amount, accrued
but unpaid monitoring fees, collection and enforcements costs (including attorneys’ fees) incurred by Lender, transfer, stamp, issuance
and similar taxes and fees incurred under this Note.


 






    	 



    	 



    

A12.
“Purchase Price Date” means the date the Purchase Price is delivered by Lender to Borrower.


A13.
“Trading Day” means any day on which the New York Stock Exchange (or such other principal market for the Common
Stock) is open for trading. For purposes of determining Borrower’s cash payment deadline under this Note, such “Trading Day”
shall exclude any day on which banking institutions in Dalian, China are authorized or required by law or other governmental action to
close.


 


[Remainder of page intentionally
left blank]